Dacomitinib

Pricing Availability   Qty
说明: Potent irreversible pan ErbB inhibitor
别名: PF00299804
化学名: (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for Dacomitinib

Dacomitinib is a potent irreversible pan ErbB inhibitor (IC50 values are 6.0, 45.7 and 73.7 nM for EGFR, ERBB2 and ERBB4, respectively). Inhibits mutant and wild type forms of ErbB, including EGFR T780M, and shows activity in NSCLC cell lines sensitive and resistant to Iressa (Cat. No. 3000). Inhibits tumor growth. Orally bioavailable.

许可信息

Sold for research purposes under agreement from Pfizer Inc.

化合物库 for Dacomitinib

Dacomitinib is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. 了解 Tocris 化合物库的更多信息。

技术数据 for Dacomitinib

分子量 469.94
公式 C24H25ClFN5O2
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 1110813-31-4
PubChem ID 11511120
InChI Key LVXJQMNHJWSHET-AATRIKPKSA-N
Smiles O=C(/C=C/CN1CCCCC1)NC2=C(OC)C=C(N=CN=C3NC4=CC=C(F)C(Cl)=C4)C3=C2

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for Dacomitinib

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
1eq. HCl 46.99 100
DMSO 46.99 100

制备储备液 for Dacomitinib

以下数据基于产品分子量 469.94。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.13 mL 10.64 mL 21.28 mL
5 mM 0.43 mL 2.13 mL 4.26 mL
10 mM 0.21 mL 1.06 mL 2.13 mL
50 mM 0.04 mL 0.21 mL 0.43 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for Dacomitinib

参考文献是支持产品生物活性的出版物。

Engelman et al (2007) PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefi. Cancer.Res. 67 11924 PMID: 18089823

Gonzales et al (2008) Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor. Mol.Cancer.Ther. 7 1880 PMID: 18606718

Li et al (2017) A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat.Cell.Biol. 19 106 PMID: 28114269


If you know of a relevant reference for Dacomitinib, please let us know.

按产品操作查看相关产品

查看全部 EGFR Inhibitors

关键词: Dacomitinib, Dacomitinib supplier, Dacomitinib, ErbB, inhibitors, inhibits, EGFR, ERBB2, ERBB4, potent, irreversible, pan-ErbB, cancer, orally, bioavailable, PF00299804, 6231, Tocris Bioscience

篇 Dacomitinib 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Dacomitinib 的引用文献。 您是否知道使用了 Tocris Dacomitinib 的优秀论文? 请告知我们.

Dacomitinib 的评论

目前没有该产品的评论。 Be the first to review Dacomitinib and earn rewards!

Have you used Dacomitinib?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.